Literature DB >> 12766077

The contribution of glycolytic and oxidative pathways to retinal photoreceptor function.

Bang V Bui1, Michael Kalloniatis, Algis J Vingrys.   

Abstract

PURPOSE: To consider how aerobic and anaerobic metabolic processes limit posthypoxemic decay in retinal function, measured by electroretinogram (ERG).
METHODS: The hypothesis that lowering metabolic demand would prolong endogenous metabolic stores was tested by comparing the rate of ERG decay in rats in dark- (n = 5) versus light-adapted (15 minutes, 112 cd/m(2), n = 5) conditions and with serial versus single (n = 5 at each of seven time points) light stimulation. Postmortem hypoxemia was induced by cervical dislocation. Glucose (10 and 100 mM) and glutamine or lactate (100 mM) were injected into the vitreous 10 minutes before hypoxemic insult, to consider glycolytic-oxidative versus oxidative metabolism, respectively.
RESULTS: Lowering the metabolic drain by light adaptation or serial stimulation significantly improved the photoreceptoral saturated amplitude during the first 5 to 7.5 minutes after postmortem hypoxemia. Increasing substrate availability with exogenous glucose preloading delayed the loss of the photoreceptoral response, thereby extending the delay constant from 4.8 to 10.9 minutes. Postreceptoral amplitudes were not improved by any exogenous substrate. Providing glucose at 5 minutes after hypoxemia provided no benefits. Similar to glucose, glutamine and lactate loading significantly delayed photoreceptoral decay over the first 7.5 minutes, after which time glucose was the more effective substrate.
CONCLUSIONS: The postmortem decay of photoreceptoral function reflects depletion of both endogenous oxygen and carbon substrate reserves. The findings provide evidence that a transition between aerobic and anaerobic metabolism occurs after approximately 8 minutes of complete hypoxemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12766077     DOI: 10.1167/iovs.02-1054

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

Review 1.  Photoreceptor degeneration: genetic and mechanistic dissection of a complex trait.

Authors:  Alan F Wright; Christina F Chakarova; Mai M Abd El-Aziz; Shomi S Bhattacharya
Journal:  Nat Rev Genet       Date:  2010-04       Impact factor: 53.242

2.  Longer lasting electroretinographic recordings from the isolated and superfused murine retina.

Authors:  Walid Albanna; Mohammed Banat; Nadeen Albanna; Maged Alnawaiseh; Sergej A Siapich; Peter Igelmund; Marco Weiergräber; Matthias Lüke; Toni Schneider
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-07-23       Impact factor: 3.117

3.  Altered visual function in monocarboxylate transporter 3 (Slc16a8) knockout mice.

Authors:  Lauren L Daniele; Brian Sauer; Shannon M Gallagher; Edward N Pugh; Nancy J Philp
Journal:  Am J Physiol Cell Physiol       Date:  2008-06-04       Impact factor: 4.249

4.  Using the electroretinogram to understand how intraocular pressure elevation affects the rat retina.

Authors:  Bang V Bui; Zheng He; Algis J Vingrys; Christine T O Nguyen; Vickie H Y Wong; Brad Fortune
Journal:  J Ophthalmol       Date:  2013-01-29       Impact factor: 1.909

5.  The effect of ageing on ocular blood flow, oxygen tension and retinal function during and after intraocular pressure elevation.

Authors:  Jeremiah K H Lim; Christine T O Nguyen; Zheng He; Algis J Vingrys; Bang V Bui
Journal:  PLoS One       Date:  2014-05-27       Impact factor: 3.240

6.  Deficient glucose and glutamine metabolism in Aralar/AGC1/Slc25a12 knockout mice contributes to altered visual function.

Authors:  Laura Contreras; Laura Ramirez; Jianhai Du; James B Hurley; Jorgina Satrústegui; Pedro de la Villa
Journal:  Mol Vis       Date:  2016-10-12       Impact factor: 2.367

7.  A Mixture of U.S. Food and Drug Administration-Approved Monoaminergic Drugs Protects the Retina From Light Damage in Diverse Models of Night Blindness.

Authors:  Henri Leinonen; Elliot H Choi; Anthony Gardella; Vladimir J Kefalov; Krzysztof Palczewski
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-04-01       Impact factor: 4.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.